Covaxin review

| Updated on October 17, 2021

The all-important technical review of Bharat Biotech’s Covaxin, by the World Health Organization (WHO), is expected this week. It is keenly watched by many in India, because their travel plans depend on the WHO’s ‘emergency use listing’ of this Covid-19 vaccine. Youngsters who are looking to study abroad and have taken Covaxin are hoping the WHO’s approval comes through, as several countries including the US have said they would recognise vaccines approved by the WHO. Despite several public health voices protesting the requirement of vaccination as a licence to travel, the practice continues across several countries.

Published on October 17, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like